1994
DOI: 10.1016/0006-8993(94)91919-4
|View full text |Cite
|
Sign up to set email alerts
|

Adenoviral vectors as functional retrograde neuronal tracers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

6
38
0

Year Published

1995
1995
2009
2009

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 75 publications
(44 citation statements)
references
References 15 publications
6
38
0
Order By: Relevance
“…16,17 We examined both X-gal-and immunoflourescenceprocessed sections for ␤-gal-positive cells in sites other than those directly injected with FIV␤-gal or Ad␤-gal. Figure 4 shows a representative example of a double-labeled SFO from an animal that had been injected with Ad␤-gal into SON (bilaterally) 3 weeks earlier.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…16,17 We examined both X-gal-and immunoflourescenceprocessed sections for ␤-gal-positive cells in sites other than those directly injected with FIV␤-gal or Ad␤-gal. Figure 4 shows a representative example of a double-labeled SFO from an animal that had been injected with Ad␤-gal into SON (bilaterally) 3 weeks earlier.…”
Section: Resultsmentioning
confidence: 99%
“…13 Ad is also known to be taken up by terminals and retrogradely transported to neuronal somata distant to the site of injection. 15,16 In contrast, when the envelop protein of the feline immunodeficiency virus is replaced by the envelop protein from the vesicular stomatitis virus (VSV-G), this VSV-G pseudotyped FIV mediates gene transfer predominantly to neurons rather than to nonneuronal cells, 17 and retrograde transport is limited to local, but not distant, neuronal somata. 17 Additionally, since FIV integrates the transgene into the host genome, transgene expression is highly stable.…”
mentioning
confidence: 99%
“…23 To determine if cell typeoratories have demonstrated the basic feasibility of theraspecific promoters would be useful in facilitating transpeutic gene delivery to peripheral and central neurons gene expression, we investigated the capacity of two with herpes simplex virus-type 1 (HSV-1) and adenovirus putative neuron-specific promoters, the neuron-specific vectors. [4][5][6][7][8][9][10][11][12][13][14] Some of these delivery systems, while enolase (NSE) promoter and the platelet-derived growth promising, present problems that may render them less factor (PDGF) B-chain promoter, to drive the expression of this reporter gene in the adult rat spinal cord. One of the difficulties encountered in using AAV as a vector is…”
Section: Cific Promoters In the Adult Spinal Cord In Anticipation Ofmentioning
confidence: 99%
“…When Adv/f3-gal vector (2.2 x 108 pfu) was injected intracerebrally, numerous virally infected cells were observed at the injection sites (Fig. 4 G and H) and some weakly stained cells could be detected in other brain areas (data not shown) presumably because of retrograde transport of the viral particles by axons projecting to the injection areas (25,26). In addition, some ,3-gal positive cells were seen in the liver and kidney (data not shown) presumably due to leakage of the viral particles into circulation during the procedure.…”
mentioning
confidence: 94%